Alzheimer's Disease Trial, By Invitation NCT07233512 Sponsor: Centre Hospitalier Universitaire de Liege Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, By Invitation

NCT07233512
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Alzheimer's disease.
  • People who agree to have a brain scan, and for whom a MRI scan is considered safe.
  • People who have at least 10 of their own teeth remaining.
  • People whose memory and thinking test score (called an MMSE) is above 15, indicating some level of cognitive function is still present.
  • People who have been assessed as having advanced gum disease, based on a dental scoring system called the DPSI (a score of 3+ or higher).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have taken part in another clinical trial within the past 30 days.
  • People for whom an MRI brain scan is not considered safe (for example, due to certain metal implants or other medical reasons).
  • People who have taken antibiotics within the last 3 months.
  • People who are currently taking medications that suppress the immune system, or who are undergoing chemotherapy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de Liege
Registry
ClinicalTrials.gov
Start date
17 November 2023
Est. completion
10 September 2029

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Cognitive status using pre-clinical Alzheimer cognitive composite (PACC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov